Recent Blogs List

Advocacy & Policy

SITC Signs onto ASGCT Letter Supporting Cancer Research Funding

posted 7 days ago
As Congress begins deliberations on Fiscal Year 2027 (FY27) appropriations, continued investment in the ...

SITC on Capitol Hill!

posted 03-11-2026
On March 4, 2026, SITC proudly joined One Voice Against Cancer's (OVAC's) 2026 Lobby Day in Washington, ...

Announcing the publication of “Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles” manuscript

posted 03-10-2026
The Society for Immunotherapy of Cancer (SITC) and the American Society for Transplantation and Cellular ...

Press Releases

Oncology News Burst from the FDA: FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma

posted 03-23-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will ...

Oncology News Burst from the FDA: FDA Approves Teclistamab in Combination with Daratumumab Hyaluronidase-fihj for Relapsed or Refractory Multiple Myeloma

posted 03-06-2026
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will ...

Oncology News Burst from the FDA: FDA Approves Durvalumab with FLOT for Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

posted 12-01-2025
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will ...

Scientific Meeting Highlights

2026 AACR Annual Meeting Scientific Highlights

posted 26 days ago
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 AACR ...

2025 ESMO IO Scientific Highlights

posted 12-12-2025
We are pleased to present highlights of the latest advances in immunotherapy emerging from the ESMO Immuno-Oncology ...

SITC 2025 Science Coverage – Nov. 9

posted 11-10-2025
Preclinical development of macrophage-targeting CAR monocytes to improve immunotherapy outcomes in breast ...

Immune Monitor Archive

Immune Monitor - April 2026

posted 5 days ago
A Message from the President Staying current in immuno-oncology has never been more important—or ...

Immune Monitor - March 2026

posted 03-27-2026
A Message from the President One of the most impactful ways the Forward Fund supports early-career ...

Immune Monitor - February 2026

posted 02-26-2026
A Message from the President The Journal for ImmunoTherapy of Cancer ( JITC ) has long been integral ...

Upcoming Events


Latest Discussions

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

JITC Digest

JITC Digest April 2026

posted 04-15-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks| JITC Meet-the-Editor Session ...

JITC Digest March 2026

posted 03-18-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|Special Series: SITC 40 th ...

JITC Digest February 2026

posted 02-18-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks| JITC Peer Review Mentorship ...